High-risk localised prostate cancer: multimodal treatment strategies combining neoadjuvant hormonal therapy and/or chemotherapy with radical prostatectomy. [electronic resource]
- Expert opinion on emerging drugs Nov 2003
- 291-5 p. digital
Publication Type: Editorial; Review
1472-8214
10.1517/14728214.8.2.291 doi
Antineoplastic Agents, Hormonal--therapeutic use Antineoplastic Combined Chemotherapy Protocols--therapeutic use Clinical Trials as Topic Combined Modality Therapy Humans Male Neoadjuvant Therapy Prostatectomy Prostatic Neoplasms--drug therapy Quality of Life Risk Assessment